Aspira Women's Health (AWH)
(Delayed Data from NSDQ)
$1.06 USD
-0.04 (-3.64%)
Updated Aug 16, 2024 03:59 PM ET
After-Market: $1.09 +0.03 (2.83%) 5:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum C VGM
Price, Consensus and EPS Surprise
AWH 1.06 -0.04(-3.64%)
Will AWH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AWH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AWH
Aspira (AWH) Reports Q2 Loss, Misses Revenue Estimates
DarioHealth Corp. (DRIO) Q2 Earnings Beat Estimates
AWH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Aspira (AWH) Reports Q1 Loss, Tops Revenue Estimates
Masimo (MASI) Beats Q4 Earnings and Revenue Estimates
Is Aspira Women's Health (AWH) Stock Outpacing Its Medical Peers This Year?
Other News for AWH
Aspira price target lowered to $5.50 from $7 at Alliance Global Partners
Aspira Womens Health Inc (AWH) Q2 2024 Earnings Call Transcript Highlights: Strong Test Volume ...
Aspira: Q2 Earnings Snapshot
Aspira Women?s Health Reports Second Quarter 2024 Financial Results
AWH Stock Earnings: Aspira Womens Health Beats EPS, Misses Revenue for Q2 2024